Sorry, no content matched your criteria.
Featured Story
"Pharma Bro" Martin Shkreli Really Upped His Weirdo Villain Game This Week
"Pharma Bro" Martin Shkreli, the CEO of Turing Pharmaceuticals, has been America's favorite corporate villain lately.
On Sept. 21, 2015, public ire for the young biopharma exec surfaced after he purchased the rights to the drug Daraprim and skyrocketed the price to $750 overnight.
Public relations in the weeks since for the young exec have only gotten worse...
"Pharma Bro" Martin Shkreli, the CEO of Turing Pharmaceuticals, has been America's favorite corporate villain lately.
On Sept. 21, 2015, public ire for the young biopharma exec surfaced after he purchased the rights to the drug Daraprim and skyrocketed the price to $750 overnight.
Public relations in the weeks since for the young exec have only gotten worse...